160 related articles for article (PubMed ID: 18702955)
1. Effects of losartan on serum total and high-molecular weight adiponectin concentrations in hypertensive patients with metabolic syndrome.
Uchida T; Shimizu M; Sakai Y; Nakano T; Hara K; Takebayashi K; Inoue T; Node K; Inukai T; Takayanagi K; Aso Y
Metabolism; 2008 Sep; 57(9):1278-85. PubMed ID: 18702955
[TBL] [Abstract][Full Text] [Related]
2. The effect of losartan and amlodipine on serum adiponectin in Japanese adults with essential hypertension.
Watanabe S; Okura T; Kurata M; Irita J; Manabe S; Miyoshi K; Fukuoka T; Murakami K; Higaki J
Clin Ther; 2006 Oct; 28(10):1677-85. PubMed ID: 17157123
[TBL] [Abstract][Full Text] [Related]
3. High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-based 6-year follow-up study in Japanese men.
Seino Y; Hirose H; Saito I; Itoh H
Metabolism; 2009 Mar; 58(3):355-60. PubMed ID: 19217451
[TBL] [Abstract][Full Text] [Related]
4. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men.
Seino Y; Hirose H; Saito I; Itoh H
Metabolism; 2007 Nov; 56(11):1493-9. PubMed ID: 17950099
[TBL] [Abstract][Full Text] [Related]
5. A lack of increase in high molecular weight-adiponectin in macroalbuminuric subjects with metabolic syndrome may exert renal and atherosclerotic risks.
Tsuda S; Nakano S; Konishi K; Koya D
Diabetes Res Clin Pract; 2008 Mar; 79(3):503-9. PubMed ID: 18006102
[TBL] [Abstract][Full Text] [Related]
6. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
[TBL] [Abstract][Full Text] [Related]
7. Increased total and high-molecular weight adiponectin after extended-release niacin.
Plaisance EP; Grandjean PW; Brunson BL; Judd RL
Metabolism; 2008 Mar; 57(3):404-9. PubMed ID: 18249215
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin multimeric complexes and the metabolic syndrome trait cluster.
Lara-Castro C; Luo N; Wallace P; Klein RL; Garvey WT
Diabetes; 2006 Jan; 55(1):249-59. PubMed ID: 16380500
[TBL] [Abstract][Full Text] [Related]
9. Changes in adiponectin multimer distribution in response to atorvastatin treatment in patients with type 2 diabetes.
von Eynatten M; Liu D; Bluemm A; Schuster T; Baumann M; Lutz J; Heemann U; Dugi KA; Nawroth PP; Bierhaus A; Humpert PM
Clin Endocrinol (Oxf); 2009 Jul; 71(1):27-32. PubMed ID: 18778396
[TBL] [Abstract][Full Text] [Related]
10. Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy.
Kato K; Osawa H; Ochi M; Kusunoki Y; Ebisui O; Ohno K; Ohashi J; Shimizu I; Fujii Y; Tanimoto M; Makino H
Clin Endocrinol (Oxf); 2008 Mar; 68(3):442-9. PubMed ID: 17970779
[TBL] [Abstract][Full Text] [Related]
11. Decreased ratio of high-molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis.
Liang KW; Lee WJ; Lee WL; Ting CT; Sheu WH
Clin Chim Acta; 2009 Jul; 405(1-2):114-8. PubMed ID: 19397903
[TBL] [Abstract][Full Text] [Related]
12. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin.
Aso Y; Yamamoto R; Wakabayashi S; Uchida T; Takayanagi K; Takebayashi K; Okuno T; Inoue T; Node K; Tobe T; Inukai T; Nakano Y
Diabetes; 2006 Jul; 55(7):1954-60. PubMed ID: 16804063
[TBL] [Abstract][Full Text] [Related]
13. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
Abe M; Okada K; Maruyama T; Matsumoto K
Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
[TBL] [Abstract][Full Text] [Related]
14. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease.
Inoue T; Kotooka N; Morooka T; Komoda H; Uchida T; Aso Y; Inukai T; Okuno T; Node K
Am J Cardiol; 2007 Aug; 100(4):569-74. PubMed ID: 17697807
[TBL] [Abstract][Full Text] [Related]
15. Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma.
Horiguchi A; Ito K; Sumitomo M; Kimura F; Asano T; Hayakawa M
Jpn J Clin Oncol; 2008 Feb; 38(2):106-11. PubMed ID: 18245516
[TBL] [Abstract][Full Text] [Related]
16. [The safety of long-term administration of losartan in current clinical practice: a non-intervention NCT-CZ 14/04/LOZ study].
Krupicka J; Ceypová K; Kristenová P; Hauser T
Vnitr Lek; 2008 Nov; 54(11):1031-8. PubMed ID: 19069675
[TBL] [Abstract][Full Text] [Related]
17. Association of serum high molecular weight adiponectin and blood pressure among non-diabetic community-dwelling men.
Kawamoto R; Tabara Y; Kohara K; Abe M; Kusunoki T; Miki T
Clin Exp Hypertens; 2011; 33(5):336-44. PubMed ID: 21529312
[TBL] [Abstract][Full Text] [Related]
18. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
[TBL] [Abstract][Full Text] [Related]
19. High molecular weight adiponectin correlates positively with myeloperoxidase in patients with type 2 diabetes mellitus.
Bobbert P; Rauch U; Stratmann B; Goldin-Lang P; Antoniak S; Bobbert T; Schultheiss HP; Tschoepe D
Diabetes Res Clin Pract; 2008 Nov; 82(2):179-84. PubMed ID: 18778866
[TBL] [Abstract][Full Text] [Related]
20. High-molecular-weight adiponectin does not predict cardiovascular events in patients with type 2 diabetes.
Krzyzanowska K; Aso Y; Mittermayer F; Inukai T; Brix J; Schernthaner G
Transl Res; 2009 Apr; 153(4):199-203. PubMed ID: 19304279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
